Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg ...

Atogepant 60 mg vs rimegepant and galcanezumab for episodic migraine prevention has superior efficacy, with comparable safety ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid. The approval is based on results from the pivotal ADEPT phase 2/3 ...

Atogepant 60 mg once daily leads to meaningful weight loss in patients with overweight or obesity receiving preventive ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte ...

Chase has announced the bonus 5% cash-back categories for the third quarter of 2025. Q4 categories will be announced on Sep. 15, 2025. January to March: Grocery stores, fitness clubs and gym ...

Looking for good, low-priced stocks to buy? Every day, the financial experts at Benzinga identify the best stocks to buy now under $5.

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...

TMBMKCA-05Y | A complete Canada 5 Year Government Bond bond overview by MarketWatch. View the latest bond prices, bond market news and bond rates.

TMBMKGB-05Y | A complete U.K. 5 Year Gilt bond overview by MarketWatch. View the latest bond prices, bond market news and bond rates.